Literature DB >> 23224719

Iatrogenic unscheduled (breakthrough) endometrial bleeding.

M Hickey1, I S Fraser.   

Abstract

Erratic, "unscheduled", vaginal bleeding continues to be the greatest disadvantage associated with widespread use of long-acting, progestogen-only methods of contraception. As a consequence, it is also the main reason for premature discontinuation of use of these methods in most cultures. From other perspectives, these methods have high acceptability, very high contraceptive efficacy and a range of valuable, added, non-contraceptive health benefits. There has been widespread awareness of the variability of these vaginal bleeding patterns associated with long-acting methods for several decades and much research has been invested into studying their patterns and implications. Considerable research has also been directed towards trying to understand the underlying mechanisms responsible for the unpredictable bleeding. Much has been clarified about the multiple mechanisms contributing to the appearance of superficial, thin-walled fragile vessels within the endometrium of many of those women with troublesome bleeding, but there is still little understanding of why some women develop these vessels and others have no fragile vessels (and may therefore develop amenorrhea). We now have several medical approaches to reliably stopping a prolonged episode of troublesome bleeding, but no good therapy to produce long-lasting relief from recurrence of erratic bleeding in predisposed women. Future understanding of the variability in individual endometrial responses in different women may be a key to solving this frustrating symptom.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224719     DOI: 10.1007/s11154-012-9227-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  40 in total

Review 1.  The analysis of menstrual bleeding patterns: a review.

Authors:  E M Belsey; T M Farley
Journal:  Contraception       Date:  1988-08       Impact factor: 3.375

2.  Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.

Authors:  Ragnheidur I Bjarnadóttir; Marjo Tuppurainen; Stephen R Killick
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

Review 3.  Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems.

Authors:  Ian S Fraser
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

4.  Clinical assessment of treatments for prolonged bleeding in users of Norplant implants.

Authors:  S Díaz; H B Croxatto; M Pavez; H Belhadj; J Stern; I Sivin
Journal:  Contraception       Date:  1990-07       Impact factor: 3.375

5.  Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey.

Authors:  David J Hooper
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.

Authors:  E M Belsey; D Machin; C d'Arcangues
Journal:  Contraception       Date:  1986-09       Impact factor: 3.375

Review 7.  The effects of Implanon on menstrual bleeding patterns.

Authors:  Diana Mansour; Tjeerd Korver; Maya Marintcheva-Petrova; Ian S Fraser
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-06       Impact factor: 1.848

Review 8.  20 microg versus >20 microg estrogen combined oral contraceptives for contraception.

Authors:  Maria F Gallo; Kavita Nanda; David A Grimes; Laureen M Lopez; Kenneth F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

9.  Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression.

Authors:  Graciela Krikun; Hilary Critchley; Frederick Schatz; Livia Wan; Rebeca Caze; Rebecca N Baergen; Charles J Lockwood
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.

Authors:  Ian S Fraser; Susanne Parke; Uwe Mellinger; Andrea Machlitt; Marco Serrani; Jeffrey Jensen
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-08       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.